Sotagliflozin

4 trials 4 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

4 Recruiting

0 Completed trials

2 Sponsors

14 Countries

Phase III

Phase II

Phase III: 2 Phase II: 2

Indications tested

Hypertrophic cardiomyopathy 1

Sponsors using this IMP

Steno Diabetes Center Copenhagen 3 Lexicon Pharmaceuticals Inc. 1

All trials

4 total

Sotagliflozin for the treatment of post-bariatric hypoglycaemia: The ONSIDE study Recruiting

2023-509118-12-00 Phase II 1 country Steno Diabetes Center Copenhagen
A study to understand if sotagliflozin improves symptoms and is safe in people with hypertrophic cardiomyopathy Recruiting

2024-513869-39-00 Phase III 13 countries Lexicon Pharmaceuticals Inc.
PLUTO - Prevention of CKD progression in type 1 diabetes with Long term Use of SGLTi avoiding kidney hypOxia Recruiting

2023-509450-55-01 Phase II 1 country Steno Diabetes Center Copenhagen
New treatments to reduce cardiovascular disease in type 1 diabetes Recruiting

2023-505794-32-04 Phase III 1 country Steno Diabetes Center Copenhagen

Showing 1–4 of 4 trials

← All drugs A–Z